{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:09:32Z","timestamp":1790712572119,"version":"4.1.0"},"reference-count":24,"publisher":"Informa UK Limited","issue":"18","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Mycovia Pharmaceuticals and Scynexis"},{"name":"Mycovia Pharmaceuticals Inc."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Microbiol."],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.2217\/fmb-2021-0173","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T09:53:47Z","timestamp":1637056427000},"page":"1453-1461","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":72,"title":["Oteseconazole: An Advance in Treatment of Recurrent Vulvovaginal Candidiasis"],"prefix":"10.1080","volume":"16","author":[{"given":"Jack D","family":"Sobel","sequence":"first","affiliation":[{"name":"Department of Internal Medicine,School of Medicine,Wayne State University,\rDetroit,\rMI\r48202,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5309-2971","authenticated-orcid":false,"given":"Paul","family":"Nyirjesy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology,Sidney Kimmel College at Thomas Jefferson University,\rPhiladelphia,\rPA\r19107,\rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.06.067"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30103-8"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2017.08.010"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000413"},{"key":"e_1_3_4_7_1","unstructured":"Sexually transmitted infections treatment guideline 2021 (2021). www.cdc.gov\/std\/treatment-guidelines\/candidiasis.htm"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0000000000000496"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/jof6010027"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2020.1791820"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2018.1476490"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ933"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2014.05.068"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-3730-3_11"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03707-14"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198612043152305"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa033114"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31827307b2"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-017-1042-z"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.03.001"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1204"},{"key":"e_1_3_4_22_1","unstructured":"Data on File. Mycovia Pharmaceuticals Inc. (2021)."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01817-16"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00185-15"},{"key":"e_1_3_4_25_1","volume-title":"Interscience Conference on Antimicrobial Agents and Chemotherapy.","author":"Fothergill AW","year":"2010","unstructured":"Fothergill AW , RinaldiMG, HoekstraWJet al. In vitro activity of two metalloenzyme inhibitors compared to caspofungin and fluconazole against a panel of 74 Candida spp. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy.MA, USA (2010)."},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00593-15"}],"container-title":["Future Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fmb-2021-0173","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T02:40:23Z","timestamp":1719110423000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fmb-2021-0173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":24,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.2217\/fmb-2021-0173"],"URL":"https:\/\/doi.org\/10.2217\/fmb-2021-0173","relation":{},"ISSN":["1746-0913","1746-0921"],"issn-type":[{"value":"1746-0913","type":"print"},{"value":"1746-0921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmb20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-03","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}